Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Adial Pharmaceuticals has raised $32.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Adial Pharmaceuticals's investors include Coastlands Capital, Stonepine Capital Management, Boxer Capital, Keystone Capital Partners, AuGC partners.
Adial Pharmaceuticals is headquartered in Charlottesville, United States.
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Adial Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adial Pharmaceuticals — Funding & Investors." VCBacked, June 11, 2026, https://www.vcbacked.co/company/adial-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2026). Adial Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/adial-pharmaceuticals
{{cite web |title=Adial Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/adial-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated